28 September 2020 1 Min Read
Inovio vaccine trial on partial hold as FDA questions device used
The Cellectra 2000 device is under the spotlight, not the actual vaccine or its positive results, yet Inovio shares dropped 35% in early trade
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In